NAPLES, Fla. and CAMBRIDGE, United Kingdom, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. (Nasdaq: CDT) (“Conduit” or the “Company”), a multi-asset, clinical stage, disease-agnostic ...
NAPLES, Fla. and CAMBRIDGE, United Kingdom - Conduit Pharmaceuticals Inc. (Nasdaq: CDT), a multi-asset clinical stage life science company with a market capitalization of $4.88 million, has announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback